Company Performance Metrics
OXHELIX develops medical AI software focused on predictive enrichment in clinical trials. The company integrates fragmented cancer-related datasets to help predict treatment success and support personalized patient care decisions. Its platform concentrates on women’s cancers, using machine learning and computational biology methods to decode
complex life sciences data. OXHELIX provides tools that researchers and clinical teams use to select and stratify trial participants and analyze outcomes. The software is designed for use in oncology drug development and related clinical research settings, supporting data-driven trial design and management. OXHELIX partners with industry programs and accelerators to test and refine its products in real-world validation studies.
